Results of liver transplantation: With or without Milan criteria?

Liver Transplantation

Volumn 13, Issue 11 SUPPL. 2, 2007, Pages

  Mazzaferro, Vincenzo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; VALIDATION PROCESS;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; HEALTH CARE RATIONING; HUMANS; LIFE EXPECTANCY; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MEDICAL ONCOLOGY; RESOURCE ALLOCATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 36448962381     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21330     Document Type: Article

References (13)

1. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al, EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2002;37: 874.
2. Bruix J, Fuster J, Llovet JM. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700-702.
3. Adam R, Azoulay D, Castaing D, Ashkenazi R, Pascal G, Hahshizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis. A reasonable strategy? Ann Surg 2003;238:508-518.
4. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-338.
5. Figueras J, Ranimos E, Ibanez I, Valls C, Serrano T, Rafecas A, et al. Surgical treatment of hepatocellular carcinoma. Long term results. Med Clin (Barc) 2002;118:410-414.
6. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003;9:513-520.
7. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, et al, for the HCC Italian Task Force. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006;44:1543-1554.
8. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996:334:693-699.
9. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
10. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durnad F, et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006;12:1761-1769.
11. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200
12. Majno P, Mazzaferro V. Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language. Liver Transpl 2006;12:896-898.
13. Marsh JW, Finkelstein SD, Demetris AJ, Swalsky PA, Sasatomi E, Bandos A, et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl 2003;9:664-671.